| Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study CM McDonald, EK Henricson, RT Abresch, T Duong, NC Joyce, F Hu, ... The Lancet 391 (10119), 451-461, 2018 | 412 | 2018 |
| Revised upper limb module for spinal muscular atrophy: development of a new module ES Mazzone, A Mayhew, J Montes, D Ramsey, L Fanelli, SD Young, ... Muscle & nerve 55 (6), 869-874, 2017 | 235 | 2017 |
| Development of the P erformance of the U pper L imb module for D uchenne muscular dystrophy A Mayhew, ES Mazzone, M Eagle, T Duong, M Ash, V Decostre, ... Developmental Medicine & Child Neurology 55 (11), 1038-1045, 2013 | 225 | 2013 |
| The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and … EK Henricson, RT Abresch, A Cnaan, F Hu, T Duong, A Arrieta, J Han, ... Muscle & nerve 48 (1), 55-67, 2013 | 225 | 2013 |
| Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study L Bello, H Gordish-Dressman, LP Morgenroth, EK Henricson, T Duong, ... Neurology 85 (12), 1048-1055, 2015 | 201 | 2015 |
| The cooperative international neuromuscular research group Duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: design of protocol … CM McDonald, EK Henricson, RT Abresch, JJ Han, DM Escolar, ... Muscle & nerve 48 (1), 32-54, 2013 | 183 | 2013 |
| Consensus-based care recommendations for adults with myotonic dystrophy type 1 T Ashizawa, C Gagnon, WJ Groh, L Gutmann, NE Johnson, G Meola, ... Neurology: Clinical Practice 8 (6), 507-520, 2018 | 164 | 2018 |
| Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled … E Mercuri, N Deconinck, ES Mazzone, A Nascimento, M Oskoui, K Saito, ... The Lancet Neurology 21 (1), 42-52, 2022 | 136 | 2022 |
| Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy MC Pera, G Coratti, N Forcina, ES Mazzone, M Scoto, J Montes, ... BMC neurology 17, 1-10, 2017 | 132 | 2017 |
| Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study L Bello, A Kesari, H Gordish‐Dressman, A Cnaan, LP Morgenroth, ... Annals of neurology 77 (4), 684-696, 2015 | 129 | 2015 |
| Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool D Ramsey, M Scoto, A Mayhew, M Main, ES Mazzone, J Montes, ... PloS one 12 (2), e0172346, 2017 | 97 | 2017 |
| Longitudinal pulmonary function testing outcome measures in Duchenne muscular dystrophy: long-term natural history with and without glucocorticoids CM McDonald, H Gordish-Dressman, EK Henricson, T Duong, NC Joyce, ... Neuromuscular Disorders 28 (11), 897-909, 2018 | 89 | 2018 |
| Ambulatory function in spinal muscular atrophy: age-related patterns of progression J Montes, MP McDermott, E Mirek, ES Mazzone, M Main, AM Glanzman, ... PLoS One 13 (6), e0199657, 2018 | 83 | 2018 |
| Revised upper limb module for spinal muscular atrophy: 12 month changes MC Pera, G Coratti, ES Mazzone, J Montes, M Scoto, R De Sanctis, ... Muscle & nerve 59 (4), 426-430, 2019 | 74 | 2019 |
| Validity and reliability of smartphone magnetometer-based goniometer evaluation of shoulder abduction–A pilot study LB Johnson, S Sumner, T Duong, P Yan, R Bajcsy, RT Abresch, E de Bie, ... Manual therapy 20 (6), 777-782, 2015 | 74 | 2015 |
| Association study of exon variants in the NF-κB and TGFβ pathways identifies CD40 as a modifier of Duchenne muscular dystrophy L Bello, KM Flanigan, RB Weiss, DM Dunn, KJ Swoboda, E Gappmaier, ... The American Journal of Human Genetics 99 (5), 1163-1171, 2016 | 70 | 2016 |
| Emerging therapies for Duchenne muscular dystrophy T Markati, M Oskoui, MA Farrar, T Duong, N Goemans, L Servais The Lancet Neurology 21 (9), 814-829, 2022 | 53 | 2022 |
| Consensus-based care recommendations for congenital and childhood-onset myotonic dystrophy type 1 NE Johnson, EZ Aldana, N Angeard, T Ashizawa, KN Berggren, ... Neurology: Clinical Practice 9 (5), 443-454, 2019 | 51 | 2019 |
| Development of a patient‐reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM K Klingels, AG Mayhew, ES Mazzone, T Duong, V Decostre, U Werlauff, ... Developmental Medicine & Child Neurology 59 (2), 224-231, 2017 | 51 | 2017 |
| Reldesemtiv in patients with spinal muscular atrophy: a phase 2 hypothesis-generating study SA Rudnicki, JA Andrews, T Duong, BM Cockroft, FI Malik, L Meng, J Wei, ... Neurotherapeutics 18 (2), 1127-1136, 2021 | 47 | 2021 |
Craig M. McDonaldUniversity of California DavisGeverifieerd e-mailadres voor ucdavis.edu
